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Abstract
Bronchoalveolar lavage (BAL) is a useful diagnostic tool in interstitial lunge diseases (ILD).
However, differential cell counts are often non specific and immunocytochemistry is time
consuming. Staining of glyoproteins by periodic acid Schiff (PAS) reaction may help in discriminating
different forms of ILD. In addition, PAS staining is easy to perform. BAL cells from patients with
idiopathic pulmonary fibrosis (IPF) (n = 8), sarcoidosis (n = 9), and extrinsic allergic alveolitis (EAA)
(n = 2) were investigated. Cytospins from BAL cells were made and cells were stained using
Hemacolor quick stain and PAS staining. Lymphocytic alveolitis was found in sarcoidosis and EAA
whereas in IPF both lymphocytes and neutrophils were increased. PAS positive cells were
significantly decreased in EAA compared to IPF and sarcoidosis (25.5% ± 0.7% vs 59.8% ± 25.1%
and 64.0% ± 19.7%, respectively) (P < 0.05). No significant correlation between PAS positive cells
and inflammatory cells was observed. These results suggest that PAS staining of BAL cells may
provide additional information in the differential diagnosis of ILD. Further studies ware warranted
to evaluate PAS staining in larger numbers of BAL from patients with ILD.
Findings
Bronchoalveolar lavage (BAL) provides an important
diagnostic tool that can facilitate the diagnosis of various
diffuse lung diseases. It can be used to determine inflam-
matory cell profiles and detect pathogens [1]. BAL cytol-
ogy and differential cell counts can even replace histology
from lung biopsies in some of the rarer lung diseases (eg.
histiocytosis X) [2]. However, in more common intersti-
tial lung disease (ILD) such as idiopathic pulmonary
fibrosis (IPF), sarcoidosis, and extrinsic allergic alveolitis
(EAA) BAL differential cell counts often cannot clearly dif-
ferentiate between the different disorders. Immuncyto-
chemistry can provide additional information but is time
consuming. Moreover, specific antibodies are expensive
and are not available at all places.
PAS (periodic-acid-Schiff) staining is used for detection of
structures that contain high concentrations of carbohy-
drate macromolecules (eg. glycogen, glycoprotein, prote-
oglycan) typically found in connective tissue, mucus, and
basal laminae. In BAL PAS staining is mostly used to diag-
nose alveolar proteinosis [2]. In ILD increased BAL fluid
levels of the glycoprotein fibronectin have been reported
[3]. Elevated levels of vitronectin another glycoprotein
have also been shown in BAL fluid of patients with inter-
stitial lung disease compared to healthy volunteers [4].
Since PAL stain is an easy method to detect glycoproteins
we hypothesized that PAS stain may add additional infor-
mation for differential diagnosis of ILD from BAL.
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BAL samples of patients with proven idiopathic pulmo-
nary fibrosis (IPF) (n = 8), with sarcoidosis (n = 9), and
with extrinsic allergic alveolitis (EAA) (n = 2) were
obtained with the help of flexible bronchoscopy. Table 1
shows the demographics of the patient groups.
In short, a total of 200 ml of sterile saline solution was
instilled in 20 ml-aliquots into the middle lobe and aspi-
rated thereafter. Following standard techniques [5] cyt-
ospins were made from BAL cells and cells were stained
using Hemacolor quick stain (Merck, Darmstadt, Ger-
many) and PAS staining. Table 2 summarizes the differen-
tial cell counts in each patient group. As expected
lymphocytic alveolitis could be observed in all groups.
Lymphocytes were significantly increased in patients with
EAA compared to the groups with IPF or sarcoidosis (P <
0.05). Neutrophils were significantly increased in IPF
patients compared to the two other groups (P < 0.05).
Figure 1 shows original PAS stained cytospins. Alveolar
macrophages (Figure 1A, B) as well as lymphocytes (Fig-
ure 1C, D) stained PAS positive. The numbers of PAS pos-
itive BAL cells from patients with EAA were significantly
lower compared to patients with IPF or sarcoidosis
(25.5% ± 0.7% vs 59.8% ± 25.1% and 64.0% ± 19.7%,
respectively) (P < 0.05) (Figure 2). No significant correla-
tion between the numbers of PAS positive cells and any
kind of inflammatory cells in the BAL was observed.
The demographics of the groups show that patients with
IPF and EAA were markedly older than patients with sar-
coidosis. This is not unusual in clinical practice since sar-
coidosis is more often observed in younger people and
IPF is typically found in older patients [6,7]. Therefore the
patient groups seem to be representative for the age and
disease.
The findings in the present study demonstrated a marked
decrease in PAS positive BAL cells in patients with EAA
compared to other interstitial lung diseases such as IPF
and sarcoidosis. However, we only investigated a very
small number of EAA patients but both patients had a low
percentage of PAS positive BAL cells (25% and 26%). This
analysis of individual data suggests that in PAS positivity
of BAL cells may be in fact reduced in EAA but this has to
be further investigated with larger numbers of samples.
We did not find a significant correlation between PAS
staining and a single cell type and I did not do double
staining to differentiate PAS positive cells. Therefore it is
not clear which inflammatory cells mostly stained posi-
tive. Future studies will have to identify whether macro-
phages, lymphocytes or neutrophils are the main source
of PAS positive material. Another option is that PAS posi-
tive proteins undergo phagocytosis by alveolar macro-
phages. In fact, several proteins (eg. surfactant proteins)
are secreted by pneumocytes [8]. These proteins have dif-
ferent functions and are also involved in pulmonary
defense. Moroever, they can opsonize pathogens and sup-
port phagocytosis. In the original microscopy in figure 1
both macrophages and lymphocytes stained PAS positive.
The staining was diffuse in some cells whereas a more
granular pattern was observed in other cells. The reason
for this remains unclear. It is tempting to speculate that
specific staining pattern may be associated with different
glycoproteins and different stages of disease. However, the
numbers examined in this study are too small to draw any
firm conclusions.
In the present study IPF, sarcoidosis and EAA were not fur-
ther subdivided into different stages of disease due to the
small numbers of patients. It may be interesting to look
whether percentage of PAS positive cells is associated with
different stages of disease (eg. active alveolitis versus fibro-
sis). However, this was beyond the scope of the present
investigation.
So far no experiments on PAS staining in other interstitial
lung disease such as pneumoconiosis or Langerhans cell
histiocytosis were performed but these studies would
clearly be very helpful to further evaluate the role of PAS
staining in discrimination of ILD. Own experiments on
patients with allergic bronchopulmonary aspergillosis
(ABPA) and pneumonia revealed a mean of PAS positive
cells of 70.5% and 47.5%, respectively. It is interesting
that in pneumonia that is commonly associated with
mucus hypersecretion the mean rate of PAS positive cells
was lower than in BAL cells from patients with sarcoidosis
or IPF. This further underlines the fact that PAS staining
identifies glycoproteins and not only mucin proteins.
In conclusion the present findings suggest that PAS stain
of BAL cells may be helpful in differential diagnosis
between EAA and other ILD. Although the numbers of
patients investigated in this study was very small we think
that further studies are warranted to evaluate the use of
PAS stain in different forms of ILD. Should future studies
prove that PAS can discriminate different ILD then this







Male:female 6:2 7:2 0:2
Mean age (years) 67.4 ± 9.9 45.4 ± 14.8 57.0 ± 19.8
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Table 2: Differential BAL cell counts in different patient groups
Group AM (%) Lymphocytes (%) Neutrophils (%) Eosinophils (%)
Pulmonary fibrosis 37.8 ± 14.7 12.4 ± 7.5 12.5 ± 13.9 1.6 ± 1.9
Sarcoidosis 70.0 ± 12.5 26.6 ± 13.9 2.2 ± 2.6 1.3 ± 1.2
EAA 7.0 ± 2.8 86.5 ± 0.7 3.0 ± 1.4 0.5 ± 0.7
AM: Alveolar macrophages. Mean ± SD
Original microscopy of PAS stained BAL cells (magnification ×400) Figure 1
Original microscopy of PAS stained BAL cells (magnification ×400). Alveolar macrophages (shown by arrow heads in 
figures 1A and 1B) as well as lymphocytes (indicated by arrows in figures 1B and 1C) stained positive (pink).Publish with BioMed Central    and   every 
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would be a very easy and less expensive tool for BAL-based
differential diagnosis.
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PAS positive cells in different patient groups Figure 2
PAS positive cells in different patient groups. Columns represent mean values ± SD. For abbreviations please refer to 
the text. *: P < 0.05 vs EAA.